Product NDC: | 68180-302 |
Proprietary Name: | cefuroxime axetil |
Non Proprietary Name: | cefuroxime axetil |
Active Ingredient(s): | 250 mg/1 & nbsp; cefuroxime axetil |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68180-302 |
Labeler Name: | LUPIN PHARMACEUTICALS INC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA065135 |
Marketing Category: | ANDA |
Start Marketing Date: | 20030725 |
Package NDC: | 68180-302-20 |
Package Description: | 20 TABLET in 1 BOTTLE (68180-302-20) |
NDC Code | 68180-302-20 |
Proprietary Name | cefuroxime axetil |
Package Description | 20 TABLET in 1 BOTTLE (68180-302-20) |
Product NDC | 68180-302 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | cefuroxime axetil |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20030725 |
Marketing Category Name | ANDA |
Labeler Name | LUPIN PHARMACEUTICALS INC |
Substance Name | CEFUROXIME AXETIL |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |